Professor Melvin Lobo is a highly accomplished Consultant Cardiovascular Physician with a focus on blood pressure disorders of all types, autonomic control of circulation, and resistant hypertension and device-based therapies thereof. He is based in the Bart's Heart Centre and the William Harvey Research Institute, where he serves as Director of the Bart's Blood Pressure Clinic, a Hypertension Centre of Excellence.

Professor Lobo is a recognised expert in the management of low blood pressure (hypotension) and BP variability disorders, as well as PoTS (postural tachycardia syndrome). He has the largest cohort of medication intolerant patients nationally and has developed specialised strategies with liquid and patch formulations of antihypertensives to circumvent intolerances to tablets.

He is a Clinical Hypertension Specialist accredited by the European Society of Hypertension (ESH) and British Hypertension Society, and is a specialist adviser to NICE and the European Society of Hypertension on interventional therapies in hypertension. He is also a member of the Council on Hypertension of the European Society of Cardiology.

Professor Lobo has contributed to several landmark studies in hypertension, particularly in the field of novel device therapy of hypertension, and his research work has been featured on television and in the national press on numerous occasions. He is a globally recognised key opinion leader in his field, with numerous roles in multicentre clinical trials, invited lectures at major conferences, and editorial positions in prestigious journals including JACC and Lancet.